Comparative Pharmacology
Head-to-head clinical analysis: BETADINE versus PHISO SCRUB.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BETADINE versus PHISO SCRUB.
BETADINE vs PHISO-SCRUB
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Povidone-iodine is an iodophor that releases free iodine, which oxidizes and iodinates microbial proteins and enzymes, leading to rapid broad-spectrum microbicidal activity against bacteria, fungi, viruses, and protozoa.
Phiso-Scrub is a topical antiseptic containing triclosan, which inhibits bacterial fatty acid synthesis by targeting enoyl-acyl carrier protein reductase (FabI), leading to disruption of cell membrane integrity and bacterial cell death.
Apply topically as a 10% povidone-iodine solution to the affected area 1-3 times daily; for preoperative skin preparation, apply as a single scrub for 5 minutes; for mouthwash/gargle, use 1% solution (diluted 1:10) 4 times daily; for vaginal use, 10% solution as a douche once daily. Not for systemic use.
Topical application to affected area once daily; chlorhexidine gluconate 4% scrub, lather for 3-5 minutes, rinse thoroughly.
None Documented
None Documented
2-7 days for iodine, prolonged in renal impairment; clinical context: topical use has minimal systemic absorption.
Approximately 8-12 hours in patients with normal renal function (CrCl >90 mL/min). Half-life is significantly prolonged in renal impairment (up to 40 hours in ESRD).
Renal: >90% as iodide; biliary/fecal <10%.
Primarily renal excretion of unchanged drug (approximately 70-80% of absorbed dose). Biliary/fecal elimination accounts for the remainder (20-30%).
Category C
Category C
Antiseptic
Antiseptic